Dramatic study results point to the potential for a steroid-sparing option for patients with the underrecognized multiorgan ...

WASHINGTON -- Patients with IgG4-related disease appeared to benefit from inebilizumab (Uplizna), currently approved for ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

Attend Pittcon 2025 in Boston to connect with global leaders in laboratory science and explore cutting-edge advancements in ...

Amgen, a global biotechnology leader highlighting profound research and development capabilities and biomanufacturing, showcases its latest achievements in the field of innovative medicines under ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other pharma stocks. Healthcare takes the concept of ‘defensive’ further than almost any ...

The new waterfront residences in East Boston already have tenants: a snail and two mussels that have snuggled into the crevices and pockets of an undulating concrete panel attached to a vertical ...

It’s been about one year since Amgen closed its $27.8 billion Horizon Therapeutics buyout and brought the rare disease drug maker’s clutch of approved therapies under its fold. With Horizon ...

My name is Julianne, and I will be your conference facilitator today for Amgen's Third Quarter 2024 Financial Results Conference Call. All lines have been placed on mute to prevent any background ...

Production on Zendaya and Robert Pattinson’s new movie “The Drama” officially kicked off in Boston, fueling an uptick in film crews and a deluge of celebrity sightings. On Thursday ...

Amgen released its third-quarter earnings report on Wednesday, revealing an overall solid performance in Q3 despite misses by some of its key products. The company’s revenues in the quarter came in at ...